Literature DB >> 11606583

Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells.

J Chen1, C Baskerville, Q Han, Z K Pan, S Huang.   

Abstract

We reported previously that endogenous p38 MAPK activity is elevated in invasive breast cancer cells and that constitutive p38 MAPK activity is important for overproduction of uPA in these cells (Huang, S., New, L., Pan, Z., Han, J., and Nemerow, G. R. (2000) J. Biol. Chem. 275, 12266-12272). However, it is unclear how elevated endogenous p38 MAPK activity is maintained in invasive breast cancer cells. In the present study, we found that blocking alpha(v) integrin functionality with a function-blocking monoclonal antibody or down-regulating alpha(v) integrin expression with alpha(v)-specific antisense oligonucleotides significantly decreased the levels of active p38 MAPK and inhibited cell-associated uPA expression in invasive breast cancer MDA-MB-231 cells. These results suggest a function link between alpha(v) integrin, p38 MAPK activity, and uPA expression in invasive tumor cells. We also found that vitronectin/alpha(v) integrin ligation specifically induced p38 MAPK activation and uPA up-regulation in invasive MDA-MB-231 cells but not in non-invasive MCF7 cells. Finally, using a panel of melanoma cells, we demonstrated that the cytoplasmic tail of alpha(v) integrin subunit is required for alpha(v) integrin ligation-induced p38 MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606583     DOI: 10.1074/jbc.M107574200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Keratinocyte-derived laminin-332 protein promotes melanin synthesis via regulation of tyrosine uptake.

Authors:  Heesung Chung; Hyejung Jung; Jung-Hyun Lee; Hye Yun Oh; Ok Bin Kim; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

2.  Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model.

Authors:  Hiroshi Kobayashi; Ryuji Yoshida; Yasufumi Kanada; Yoichi Fukuda; Tatsuo Yagyu; Kiyokazu Inagaki; Toshiharu Kondo; Noriyuki Kurita; Mika Suzuki; Naohiro Kanayama; Toshihiko Terao
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-10       Impact factor: 4.553

3.  Collagen fragments inhibit hyaluronan synthesis in skin fibroblasts in response to ultraviolet B (UVB): new insights into mechanisms of matrix remodeling.

Authors:  Katharina Röck; Maria Grandoch; Marc Majora; Jean Krutmann; Jens W Fischer
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

4.  Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.

Authors:  Catalina Suarez-Cuervo; Melinda A Merrell; Latania Watson; Kevin W Harris; Eben L Rosenthal; H Kalervo Väänänen; Katri S Selander
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.

Authors:  Laetitia Devy; Shafaat A Rabbani; Mark Stochl; Mary Ruskowski; Ian Mackie; Laurent Naa; Mark Toews; Reinoud van Gool; Jie Chen; Art Ley; Robert C Ladner; Daniel T Dransfield; Paula Henderikx
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

6.  Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.

Authors:  Herbert B Schiller; Andreas Szekeres; Bernd R Binder; Hannes Stockinger; Vladimir Leksa
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

7.  Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase.

Authors:  James W Antoon; Melyssa R Bratton; Lori M Guillot; Scott Wadsworth; Virgilio A Salvo; Steven Elliott; John A McLachlan; Matthew E Burow
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

8.  Differences in integrin expression and signaling within human breast cancer cells.

Authors:  Aliakbar Taherian; Xinlei Li; Yongqing Liu; Thomas A Haas
Journal:  BMC Cancer       Date:  2011-07-13       Impact factor: 4.430

9.  Interfering with TGFbeta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expression.

Authors:  Ralph K Lindemann; Alfred Nordheim; Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-03-19       Impact factor: 27.401

10.  No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype.

Authors:  S E Bojesen; A Tybjaerg-Hansen; C K Axelsson; B G Nordestgaard
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.